Van Rechem Capucine, Black Joshua C, Boukhali Myriam, Aryee Martin J, Gräslund Susanne, Haas Wilhelm, Benes Cyril H, Whetstine Johnathan R
Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, Massachusetts.
Massachusetts General Hospital Department of Pathology and Department of Medicine, Harvard Medical School, Charlestown, Massachusetts.
Cancer Discov. 2015 Mar;5(3):255-63. doi: 10.1158/2159-8290.CD-14-1326. Epub 2015 Jan 6.
Chromatin-modifying enzymes are predominantly nuclear; however, these factors are also localized to the cytoplasm, and very little is known about their role in this compartment. In this report, we reveal a non-chromatin-linked role for the lysine-specific demethylase KDM4A. We demonstrate that KDM4A interacts with the translation initiation complex and affects the distribution of translation initiation factors within polysome fractions. Furthermore, KDM4A depletion reduced protein synthesis and enhanced the protein synthesis suppression observed with mTOR inhibitors, which paralleled an increased sensitivity to these drugs. Finally, we demonstrate that JIB-04, a JmjC demethylase inhibitor, suppresses translation initiation and enhances mTOR inhibitor sensitivity. These data highlight an unexpected cytoplasmic role for KDM4A in regulating protein synthesis and suggest novel potential therapeutic applications for this class of enzyme.
This report documents an unexpected cytoplasmic role for the lysine demethylase KDM4A. We demonstrate that KDM4A interacts with the translation initiation machinery, regulates protein synthesis and, upon coinhibition with mTOR inhibitors, enhances the translation suppression and cell sensitivity to these therapeutics.
染色质修饰酶主要定位于细胞核;然而,这些因子也存在于细胞质中,而关于它们在这个区室中的作用却知之甚少。在本报告中,我们揭示了赖氨酸特异性去甲基化酶KDM4A的一种非染色质相关作用。我们证明KDM4A与翻译起始复合物相互作用,并影响多核糖体组分中翻译起始因子的分布。此外,KDM4A的缺失降低了蛋白质合成,并增强了用mTOR抑制剂观察到的蛋白质合成抑制,这与对这些药物的敏感性增加相平行。最后,我们证明JmjC去甲基化酶抑制剂JIB-04抑制翻译起始并增强mTOR抑制剂敏感性。这些数据突出了KDM4A在调节蛋白质合成中意想不到的细胞质作用,并提示了这类酶新的潜在治疗应用。
本报告记录了赖氨酸去甲基化酶KDM4A意想不到的细胞质作用。我们证明KDM4A与翻译起始机制相互作用,调节蛋白质合成,并且在与mTOR抑制剂共同抑制时,增强翻译抑制和细胞对这些治疗药物的敏感性。